These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15804728)

  • 1. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
    Peeyananjarassri K; Baber R
    Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
    Crandall C
    J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
    Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
    Johansen OE; Qvigstad E
    Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    van de Weijer PH; Mattsson LA; Ylikorkala O
    Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Ettinger B
    Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
    Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
    Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse Romande; 2002 Aug; 122(8):377-81. PubMed ID: 12357730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin.
    Xing S; Wu Y; Liu J; Xu R; Zhang Z; Wang Y
    Chin Med J (Engl); 2003 Apr; 116(4):584-7. PubMed ID: 12875727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH; Mirkin S
    Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy in menopausal women: Past problems and future possibilities.
    Schmidt JW; Wollner D; Curcio J; Riedlinger J; Kim LS
    Gynecol Endocrinol; 2006 Oct; 22(10):564-77. PubMed ID: 17135036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogen therapies: differences in clinical effects?
    Wiegratz I; Kuhl H
    Trends Endocrinol Metab; 2004 Aug; 15(6):277-85. PubMed ID: 15358281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
    Woodis CB
    J Pharm Pract; 2010 Dec; 23(6):540-7. PubMed ID: 21507860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.
    Honebrink A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):619-41. PubMed ID: 16083332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of low-dose reproductive hormone therapies in China.
    Ge Q; Tian Q; Tseng H; Naftolin F
    Gynecol Endocrinol; 2006 Nov; 22(11):636-45. PubMed ID: 17145650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy (HT) in patients with breast cancer.
    Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
    Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
    Kwee SH; Tan HH; Marsman A; Wauters C
    Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.